![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 16, 2021 5:22:03 PM
"to extend the date by which Big Rock has to consummate its initial business combination from April 23, 2021 to May 24, 2021"
https://ih.advfn.com/stock-market/NASDAQ/big-rock-partners-acquis-BRPA/stock-news/84779834/additional-proxy-soliciting-materials-definitive-d
NRXP;
NeuroRx established a commercial development partnership with Relief Therapeutics Holding AG (SWX:RLF, OTCQB:RLFTF) ("Relief") in March 2020 for global commercialization of aviptadil which has been the subject of previous press releases.
More time for NRXP.
The 'Jewel' is still RLF-100. Dispite the retorect from NRX the partnership is Relief 80-20% throughout the WORLD and 50-50% US/I/Ca for commercialization of RLF-100.
New Swiss and Turkey Inhaler Trials for Aviptadil by RLF are super significant, IMO.
NRX better get MOVING FAST or their deal passes away.
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM